Join FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics. The program will be on hiatus starting Jan. 20, 2021.
Join FDA Commissioner Stephen M. Hahn, M.D. and Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D. for their final episode of FDA...
Frank Yiannas, FDA’s Deputy Commissioner for Food Policy and Response, joins Dr. Shah for a discussion on the New Era of Smarter Food Safety and how i...
Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its...
Dr. Jeffrey C. Baker, Deputy Director of the FDA’s Office of Biotechnology Products in the Center for Drug Evaluation and Research, joins Dr. Shah for...
Dr. Anand Shah and Rear Adm. Richardae Araojo, Associate Commissioner of Minority Health, discuss the FDA’s efforts to address minority health dispari...
Dr. Shah welcomes Dr. Janet Maynard, director of FDA’s Office of Orphan Products Development, for a discussion on the agency’s work advancing evaluati...
Dr. Shah welcomes Dr. Suzanne Schwartz, director of FDA’s Office of Strategic Partnerships and Technology Innovation at the Center for Devices and Rad...
On this week's episode, Dr. Shah brings Dr. Peter Marks back to the show to discuss the importance of getting the flu vaccine. For more information ab...
Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 va...